- Home
- TRIB vs COCP Comparison
TRIB vs COCP Comparison
Compare TRIB & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRIB
- COCP
- Stock Information
- Founded
- TRIB 1992
- COCP N/A
- Country
- TRIB Ireland
- COCP United States
- Employees
- TRIB N/A
- COCP N/A
- Industry
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- TRIB Health Care
- COCP Health Care
- Exchange
- TRIB Nasdaq
- COCP Nasdaq
- Market Cap
- TRIB 15.9M
- COCP 18.2M
- IPO Year
- TRIB N/A
- COCP N/A
- Fundamental
- Price
- TRIB $1.55
- COCP $2.10
- Analyst Decision
- TRIB
- COCP Strong Buy
- Analyst Count
- TRIB 0
- COCP 1
- Target Price
- TRIB N/A
- COCP $7.00
- AVG Volume (30 Days)
- TRIB 158.6K
- COCP 18.2K
- Earning Date
- TRIB 08-14-2024
- COCP 11-11-2024
- Dividend Yield
- TRIB N/A
- COCP N/A
- EPS Growth
- TRIB N/A
- COCP N/A
- EPS
- TRIB N/A
- COCP N/A
- Revenue
- TRIB $58,652,000.00
- COCP N/A
- Revenue This Year
- TRIB $17.64
- COCP N/A
- Revenue Next Year
- TRIB $9.84
- COCP N/A
- P/E Ratio
- TRIB N/A
- COCP N/A
- Revenue Growth
- TRIB 8.60
- COCP N/A
- 52 Week Low
- TRIB $1.05
- COCP $1.33
- 52 Week High
- TRIB $3.55
- COCP $3.10
- Technical
- Relative Strength Index (RSI)
- TRIB 48.81
- COCP 64.12
- Support Level
- TRIB $1.52
- COCP $1.66
- Resistance Level
- TRIB $1.83
- COCP $2.45
- Average True Range (ATR)
- TRIB 0.16
- COCP 0.16
- MACD
- TRIB 0.04
- COCP 0.04
- Stochastic Oscillator
- TRIB 50.00
- COCP 53.33
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).